BioSpace News Archive

In response to new nationwide mask and testing mandates, Vivera Pharmaceuticals has expanded access to testing resources, vaccine clinics, and personal protective equipment (PPE).

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, based on its patented biophotonic technology, announced today that an independent study of 166 women in Hungary showed that LuViva detected 20% more cervical precancer and cancer than the HPV test

Children’s Hospital of Philadelphia and the American Heart Association have announced an enhanced collaboration to advance the next generation of pediatric emergency cardiovascular care and resuscitation practices.

Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, announced the completion of a $90 million Series C financing, bringing the company’s total financing to over $130 million since the company’s inception.

The American Hospital Association Board of Trustees has elected John Haupert, President and CEO of Grady Health System, as its Chair-elect Designate.

Oncopeptides AB, a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, announces that the US Food and Drug Administration, FDA, has issued a safety alert to patients and health care professionals, regarding an increased risk of death associated with Pepaxto®, in the OCEAN study.

The prenatal and newborn genetic testing market was valued at US$ 4,034.4 million in 2018 and it is projected to reach US$ 11,204.7 million in 2027; it is expected to grow at a CAGR of 12.2% from 2019 to 2027.

Rise in usage of animal models in virology and infectious diseases and increase in adoption of CRISPR technology drive the growth of the global animal model market.

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

Stilla Technologies, the company innovating the next generation of digital PCR solutions for life science research and molecular diagnostics, is pleased to announce the launch of its 6-Color Digital PCR Access Program which enables early access to the industry’s first Digital PCR system featuring six fluorescent channels for providing the highest multiplexing and detection capacity available on the market today.